Search

Venkataraman Balasubramanian

Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1611
Total Applications
2999
Issued Applications
2017
Pending Applications
254
Abandoned Applications
728

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4596624 [patent_doc_number] => 07982062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Process for the preparation of cholanic acids' [patent_app_type] => utility [patent_app_number] => 11/853632 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1490 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982062.pdf [firstpage_image] =>[orig_patent_app_number] => 11853632 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/853632
Process for the preparation of cholanic acids Sep 10, 2007 Issued
Array ( [id] => 5198671 [patent_doc_number] => 20070297989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/851125 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11434 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20070297989.pdf [firstpage_image] =>[orig_patent_app_number] => 11851125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/851125
NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVES Sep 5, 2007 Abandoned
Array ( [id] => 4904538 [patent_doc_number] => 20080113952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Combination Therapy For Treating Heart Disease' [patent_app_type] => utility [patent_app_number] => 11/847660 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9695 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113952.pdf [firstpage_image] =>[orig_patent_app_number] => 11847660 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/847660
Combination Therapy For Treating Heart Disease Aug 29, 2007 Abandoned
Array ( [id] => 4728032 [patent_doc_number] => 20080207576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Substituted sapogenins and their use' [patent_app_type] => utility [patent_app_number] => 11/895095 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10518 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207576.pdf [firstpage_image] =>[orig_patent_app_number] => 11895095 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/895095
Substituted sapogenins and their use Aug 22, 2007 Abandoned
Array ( [id] => 7724361 [patent_doc_number] => 08097632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Inhibitors of hedgehog signaling pathways, compositions and uses related thereto' [patent_app_type] => utility [patent_app_number] => 11/894712 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 53 [patent_no_of_words] => 39057 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097632.pdf [firstpage_image] =>[orig_patent_app_number] => 11894712 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894712
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto Aug 19, 2007 Issued
Array ( [id] => 4860662 [patent_doc_number] => 20080269512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Large Scale Method for the deoxofluorination of ketones' [patent_app_type] => utility [patent_app_number] => 11/841202 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2578 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269512.pdf [firstpage_image] =>[orig_patent_app_number] => 11841202 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/841202
Large Scale Method for the deoxofluorination of ketones Aug 19, 2007 Abandoned
Array ( [id] => 4734431 [patent_doc_number] => 20080051411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof' [patent_app_type] => utility [patent_app_number] => 11/840477 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16534 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051411.pdf [firstpage_image] =>[orig_patent_app_number] => 11840477 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/840477
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof Aug 16, 2007 Abandoned
Array ( [id] => 4688775 [patent_doc_number] => 20080032956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => '2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds' [patent_app_type] => utility [patent_app_number] => 11/839586 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8082 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032956.pdf [firstpage_image] =>[orig_patent_app_number] => 11839586 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/839586
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds Aug 15, 2007 Issued
Array ( [id] => 4899832 [patent_doc_number] => 20080119446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Prodrugs for Use as Ophthalmic Agents' [patent_app_type] => utility [patent_app_number] => 11/838676 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11151 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119446.pdf [firstpage_image] =>[orig_patent_app_number] => 11838676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/838676
Quinol compound and pharmaceutical composition Aug 13, 2007 Issued
Array ( [id] => 4933475 [patent_doc_number] => 20080004250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Compounds and Formulations' [patent_app_type] => utility [patent_app_number] => 11/838154 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16875 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004250.pdf [firstpage_image] =>[orig_patent_app_number] => 11838154 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/838154
Steroids having 1,8-unsaturation and formulations comprising same Aug 12, 2007 Issued
Array ( [id] => 4797886 [patent_doc_number] => 20080009472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Prostate Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 11/837508 [patent_app_country] => US [patent_app_date] => 2007-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16871 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009472.pdf [firstpage_image] =>[orig_patent_app_number] => 11837508 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/837508
Prostate cancer treatment Aug 10, 2007 Issued
Array ( [id] => 6626172 [patent_doc_number] => 20100172870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/377169 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21818 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172870.pdf [firstpage_image] =>[orig_patent_app_number] => 12377169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377169
METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION Aug 7, 2007 Abandoned
Array ( [id] => 5199138 [patent_doc_number] => 20070298456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/826633 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10687 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298456.pdf [firstpage_image] =>[orig_patent_app_number] => 11826633 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/826633
Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof Jul 16, 2007 Abandoned
Array ( [id] => 4894020 [patent_doc_number] => 20080103119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS' [patent_app_type] => utility [patent_app_number] => 11/777830 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5673 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103119.pdf [firstpage_image] =>[orig_patent_app_number] => 11777830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/777830
Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists Jul 12, 2007 Issued
Array ( [id] => 5016634 [patent_doc_number] => 20070259843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Methods and Compositions for Treatment of Macular and Retinal Disease' [patent_app_type] => utility [patent_app_number] => 11/777825 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11182 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259843.pdf [firstpage_image] =>[orig_patent_app_number] => 11777825 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/777825
Methods and compositions for treatment of macular and retinal disease Jul 12, 2007 Issued
Array ( [id] => 4803785 [patent_doc_number] => 20080015374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'METHOD FOR THE SYNTHESIS AND ISOLATION OF PHYTOSTEROL ESTERS' [patent_app_type] => utility [patent_app_number] => 11/776181 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4183 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015374.pdf [firstpage_image] =>[orig_patent_app_number] => 11776181 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/776181
METHOD FOR THE SYNTHESIS AND ISOLATION OF PHYTOSTEROL ESTERS Jul 10, 2007 Abandoned
Array ( [id] => 4880404 [patent_doc_number] => 20080153787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => '18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same' [patent_app_type] => utility [patent_app_number] => 11/769952 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6709 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153787.pdf [firstpage_image] =>[orig_patent_app_number] => 11769952 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/769952
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same Jun 27, 2007 Issued
Array ( [id] => 8690045 [patent_doc_number] => 08389573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Glycyrrhetinic acid derivatives' [patent_app_type] => utility [patent_app_number] => 12/308798 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 25362 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12308798 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/308798
Glycyrrhetinic acid derivatives Jun 26, 2007 Issued
Array ( [id] => 4846424 [patent_doc_number] => 20080182832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions' [patent_app_type] => utility [patent_app_number] => 11/819517 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 14395 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182832.pdf [firstpage_image] =>[orig_patent_app_number] => 11819517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/819517
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Jun 26, 2007 Issued
Array ( [id] => 4853172 [patent_doc_number] => 20080318915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE' [patent_app_type] => utility [patent_app_number] => 11/765657 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2925 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318915.pdf [firstpage_image] =>[orig_patent_app_number] => 11765657 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/765657
DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE Jun 19, 2007 Abandoned
Menu